Home > Healthcare > Medical Devices > Therapeutic Devices > Lipid Nanoparticle Raw Materials Market

Lipid Nanoparticle Raw Materials Market Trends

Report ID: GMI9266
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Lipid Nanoparticle Raw Materials Market Trends

Advancements in drug delivery have empowered the creation of lipid nanoparticles boasting superior attributes such as stability, biocompatibility, and targeted delivery. These enhancements are made possible by employing advanced lipid materials such as phospholipids, cholesterol, and diverse surfactants
.

Such tailored lipid compositions enable the customization of nanoparticle characteristics to suit specific therapeutic needs. Therefore, the escalating demand for top-tier raw materials to fuel the production of advanced lipid nanoparticles remains a driving force propelling growth in the market.
The biopharmaceutical industry is experiencing rapid expansion, driven by the increasing demand for biologics and personalized medicine.
Lipid nanoparticles play a crucial role in the delivery of biologics, such as nucleic acids (e.g., mRNA, siRNA) and protein-based therapeutics, by overcoming challenges related to their stability, delivery, and immunogenicity.
Thus, as the biopharmaceutical industry continues to grow, the demand for lipid nanoparticle raw materials is expected to rise significantly.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Lipid nanoparticle raw materials market size was USD 227.4 million in 2023 and is expected to register 5.7% CAGR from 2024-2032 owing to the rise in chronic diseases such as cancer, diabetes, and cardiovascular disorders worldwide.

Lipid nanoparticle raw materials industry from the kits segment is expected to reach USD 195.1 million by 2032 due to a rising demand for specialized lipid components such as ionizable lipids, PEGylated lipids, sterol lipids, and neutral phospholipids, essential for formulating lipid nanoparticles.

North America lipid nanoparticle raw materials industry reached USD 92.5 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the rising incidence of chronic ailments like cancer and diabetes in the region.

Biopharma PEG Scientific Inc., BroadPharm, CordenPharma, Creative Biolabs, Croda International Plc, Echelon Biosciences, Merck KGaA, NOF Corporation, Polysciences, Inc., and Tebubio, are some of the major lipid nanoparticle raw materials companies worldwide.